早期临床试验单元瘤板:国家癌症网络中的现实体验
L Weiss1,2, K Dorman1,3,2, M Boukovala1,2
1Department Medicine III (Hematology and Oncology), LMU University Hospital Munich, Munich, Germany.
Journal of cancer research and clinical oncology
|July 25, 2023
概括
巴伐利亚医院的虚拟网络成功讨论了43名晚期癌症患者的早期临床试验选择. 早期临床试验单位瘤委员会提供了治疗建议,改善了患者获得创新疗法的机会.
科学领域:
- 在瘤学瘤学.
- 临床试验管理 临床试验管理
- 数字健康数字健康
背景情况:
- 早期临床试验对于开发新的癌症疗法至关重要.
- 对于患有晚期疾病的患者来说,获得早期临床试验可能是一个挑战.
- 巴伐利亚大学医院建立了一个虚拟网络,以促进患者的讨论.
研究的目的:
- 建立和评估一个虚拟网络平台,讨论早期临床试验的选择.
- 通过协作虚拟瘤委员会,改善患者获得创新的癌症治疗方法.
主要方法:
- 实施了一个虚拟的早期临床试验单元瘤委员会 (ECTU瘤委员会).
- 进行了基于网络的安全会议,以评估患者病例.
- 对2021年11月至2022年11月期间讨论的患者病例的回顾性分析.
主要成果:
- 讨论了43名患有不同瘤实体的患者.
- 83.7%的患者至少收到了一个临床试验建议.
- 建议进行21项不同的试验,包括抗体,BiTE,CAR T细胞和化疗选择.
结论:
- 欧共体瘤委员会是虚拟患者讨论的一个可行和成功的模型.
- 这个网络增强了患者护理和高级疾病的试验招聘.
- 它提供了额外的治疗选择,弥合了临床试验访问的差距.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
Cancer Survival Analysis
386
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
386
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


